PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells
Ziyu Chen(Macau University of Science and Technology), Shailesh Agarwal(Brigham and Women's Hospital), Sarah Djeddi(Centre National de la Recherche Scientifique), Indranil Sinha(Brigham and Women's Hospital), Ulrich H. von Andrian(Harvard University), Arin K. Greene(Boston Children's Hospital), C. Ronald Kahn(Joslin Diabetes Center), María Gutiérrez‐Arcelus(Broad Institute), Vicki Rosen(Harvard University), Mengfan Wu(Peking University Shenzhen Hospital), Olga Barreiro(Spanish National Centre for Cardiovascular Research), Timothy P. Padera(Massachusetts General Hospital), John McNamara(Rutgers, The State University of New Jersey), Soheila Ali Akbari Ghavimi(Harvard University), Babak J. Mehrara(Memorial Sloan Kettering Cancer Center), Radomir Kratchmarov(Brigham and Women's Hospital), Dennis P. Orgill(Brigham and Women's Hospital), Patrick J. Brennan(Harvard University), Ashley Siegel(Brigham and Women's Hospital), David E. Maridas(Harvard University)
Cited by 14
Related Papers
Lineage relationship and protective immunity of memory CD8 T cell subsets
|Nature Immunology|2003|1.9k
Antioxidants prevent health-promoting effects of physical exercise in humans
|Proceedings of the National Academy of Sciences|2009|1.6k
Vitamin effects on the immune system: vitamins A and D take centre stage
|Nature reviews. Immunology|2008|1.6k